Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Peijia Medical
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
Achieva Medical Entered into an Exclusive Distribution Agreement with NowYon Medical
2024-08-28 16:40
Peijia Medical Announces 2024 Interim Results
2024-08-26 20:30
Peijia Medical's Licensing Partner, JenaValve Technology, Inc., is Expected to be Acquired by Edwards Lifesciences
2024-07-25 20:30
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
2024-06-17 20:30
Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio™ Transcatheter Aortic Regurgitation Clinical Trial
2024-01-29 21:00
inQB8 Medical Technologies LLC and Peijia Medical Limited Report Successful First-in-Human (FIH) Implantation of MonarQ Transcatheter Tricuspid Valve Replacement (TTVR) System in The United States of America
2023-12-05 21:00
Peijia Medical Presents Early Clinical Findings of GeminiOne® TEER Device at TCT 2023
2023-10-27 20:00
Peijia Medical Announces 2023 Interim Results
2023-09-01 19:00
Peijia Medical Announces First Chinese Patient Implanted with TaurusTrio™ Transcatheter Aortic Valve Replacement System
2023-08-01 20:00
Peijia Medical Limited and inQB8 Medical Technologies, LLC report Successful First-in-Human implantation of MonarQ Transcatheter Tricuspid Valve Replacement System
2022-11-25 16:00
Peijia Medical Obtained Exclusive License for JenaValve's Trilogy TAVR System for Treating AR in the Greater China Region
2022-01-19 20:00
Peijia Medical's New Milestone Asia's first successful clinical case using HighLife transseptal mitral valve replacement technology
2021-12-30 19:18
Peijia Medical Announces First Patient Implant in the Clinical Trial of its Third-Generation Transcatheter Aortic Valve System TaurusNXT®
2021-09-14 22:11
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant
2021-09-06 13:44
With the Second-Generation transcatheter aortic valve replacement system approved for marketing, Peijia Medical leads China into the "Retrievable Era" using TAVR products
2021-06-28 11:15
Peijia Medical's Jasper® SS Detachable Coil Receives NMPA Approval for Commercialization
2021-06-25 00:27
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product
2021-06-10 10:26
Peijia Medical's TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization
2021-04-25 08:53
Peijia Medical and HighLife Enter Into License and Technology Transfer Agreement for Transeptal Mitral Valve Replacement in Greater China
2020-12-21 10:00
Peijia Medical Successfully Commenced Animal Study for its Mitral Valve Edge-to-Edge Repair Product
2020-12-08 20:00
1